Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone
Authors
Keywords
-
Journal
HYPERTENSION RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-20
DOI
10.1038/s41440-020-00569-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mineralocorticoid Receptor Blockers: Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonists
- (2020) Daisuke Sueta et al. CURRENT HYPERTENSION REPORTS
- Hyperkalaemia: aetiology, epidemiology, and clinical significance
- (2019) Jasper Tromp et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- Esaxerenone: First Global Approval
- (2019) Sean Duggan DRUGS
- Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
- (2019) Yanhuan Feng et al. American Journal of Cardiovascular Drugs
- Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study
- (2019) Sadayoshi Ito et al. JOURNAL OF HUMAN HYPERTENSION
- Physiology and Pathophysiology of Potassium Homeostasis: Core Curriculum 2019
- (2019) Biff F. Palmer et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria
- (2019) Sadayoshi Ito et al. Clinical Journal of the American Society of Nephrology
- Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study
- (2019) Hiroshi Itoh et al. HYPERTENSION RESEARCH
- JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―
- (2019) Hiroyuki Tsutsui et al. CIRCULATION JOURNAL
- Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension
- (2019) Hiromi Rakugi et al. HYPERTENSION RESEARCH
- Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment
- (2019) Akifumi Kurata et al. ADVANCES IN THERAPY
- Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study
- (2019) Andrew Whittaker et al. CTS-Clinical and Translational Science
- Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
- (2019) Sadayoshi Ito et al. HYPERTENSION
- Single- and multiple-dose escalation study to assess pharmacokinetics, pharmacodynamics and safety of oral esaxerenone in healthy Japanese subjects
- (2018) Manabu Kato et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Double-Blind, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Eplerenone in Japanese Patients With Chronic Heart Failure (J-EMPHASIS-HF)
- (2018) Hiroyuki Tsutsui et al. CIRCULATION JOURNAL
- Hyperkalaemia in people with diabetes: occurrence, risk factors and outcomes in a Danish population-based cohort study
- (2018) R. W. Thomsen et al. DIABETIC MEDICINE
- Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function
- (2018) Adamasco Cupisti et al. Nutrients
- Malnutrition in Chronic Kidney Disease
- (2018) Franca M. Iorember Frontiers in Pediatrics
- Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients
- (2018) Jean Jacques Noubiap et al. HEART
- Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options
- (2018) Luca Di Lullo et al. CardioRenal Medicine
- Associations of serum potassium levels with mortality in chronic heart failure patients
- (2017) Mette Aldahl et al. EUROPEAN HEART JOURNAL
- Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
- (2017) Erik Nilsson et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
- (2017) Peter Kolkhof et al. JOURNAL OF ENDOCRINOLOGY
- How Dangerous Is Hyperkalemia?
- (2017) John R. Montford et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults
- (2017) Kumar Dharmarajan et al. Heart Failure Clinics
- Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality
- (2017) Julio Núñez et al. CIRCULATION
- Physiology and pathophysiology of potassium homeostasis
- (2016) Biff F. Palmer et al. ADVANCES IN PHYSIOLOGY EDUCATION
- Add-On Use of Eplerenone Is Effective for Lowering Home and Ambulatory Blood Pressure in Drug-Resistant Hypertension
- (2016) Kazuo Eguchi et al. Journal of Clinical Hypertension
- Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium
- (2016) George C. Roush et al. JOURNAL OF HYPERTENSION
- Hyperkalemia in Heart Failure
- (2016) Chaudhry M.S. Sarwar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Heart failure and kidney dysfunction: epidemiology, mechanisms and management
- (2016) Joerg C. Schefold et al. Nature Reviews Nephrology
- Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future
- (2016) Patrick Rossignol et al. PHARMACOLOGICAL RESEARCH
- Electrophysiological and clinical consequences of hyperkalemia
- (2016) Vito M. Campese et al. Kidney International Supplements
- Prevalence of Hyperkalemia in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease: A Nested Case-Control Study
- (2015) Charalampos Loutradis et al. AMERICAN JOURNAL OF NEPHROLOGY
- Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function
- (2015) J. Luo et al. Clinical Journal of the American Society of Nephrology
- Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice
- (2015) Alexander Michel et al. EUROPEAN JOURNAL OF HEART FAILURE
- Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist
- (2015) Kiyoshi Arai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
- (2015) Kiyoshi Arai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone
- (2015) Mitja Lainscak et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
- (2015) Bryan Williams et al. LANCET
- Drug-Induced Hyperkalemia
- (2014) Chaker Ben Salem et al. DRUG SAFETY
- Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: Systematic review and meta-analysis
- (2014) Francesco Pelliccia et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
- (2013) Patrick Rossignol et al. Circulation-Heart Failure
- Serum potassium levels and the risk of atrial fibrillation
- (2013) Bouwe P. Krijthe et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease
- (2012) Nishank Jain et al. AMERICAN JOURNAL OF CARDIOLOGY
- Clinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
- (2012) Michael H. Alderman et al. HYPERTENSION
- Mineralocorticoid receptor antagonists: their use and differentiation in Japan
- (2012) Atsuhisa Sato HYPERTENSION RESEARCH
- Serum Potassium Levels and Mortality in Acute Myocardial Infarction
- (2012) Abhinav Goyal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension
- (2012) GianLuca Colussi et al. JOURNAL OF HYPERTENSION
- Metabolic Complications in Elderly Adults with Chronic Kidney Disease
- (2012) Paul E. Drawz et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy
- (2012) Sara S. Roscioni et al. Nature Reviews Nephrology
- The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease
- (2011) Nicola C. Edwards et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
- (2011) Marsha A. Raebel Cardiovascular Therapeutics
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
- (2011) E. Imai et al. DIABETOLOGIA
- Aldosterone Blockers (Mineralocorticoid Receptor Antagonism) and Potassium-Sparing Diuretics
- (2011) Murray Epstein et al. Journal of Clinical Hypertension
- Hypokalemia and Outcomes in Patients With Chronic Heart Failure and Chronic Kidney Disease
- (2010) C. Barrett Bowling et al. Circulation-Heart Failure
- Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring
- (2010) Marsha A. Raebel et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy
- (2010) Jodi Heshka et al. Journal of the American Society of Hypertension
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution
- (2010) Jasmeet Soar et al. RESUSCITATION
- Addition of Spironolactone to Dual Blockade of Renin Angiotensin System Dramatically Reduces Severe Proteinuria in Renal Transplant Patients: An Uncontrolled Pilot Study at 6 Months
- (2010) E. González Monte et al. TRANSPLANTATION PROCEEDINGS
- Risk of Hyperkalemia in Nondiabetic Patients With Chronic Kidney Disease Receiving Antihypertensive TherapyHyperkalemia in CKD Adults Using Antihypertensives
- (2009) Joy M. Weinberg ARCHIVES OF INTERNAL MEDICINE
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Spironolactone on Urinary Protein Excretion in Patients with Chronic Kidney Disease
- (2009) Erkan Sengul et al. RENAL FAILURE
- Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial
- (2008) Leszek Tylicki et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Retrospective Review of the Frequency of ECG Changes in Hyperkalemia
- (2008) B. T. Montague et al. Clinical Journal of the American Society of Nephrology
- Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker
- (2008) Yoshiyuki FURUMATSU et al. HYPERTENSION RESEARCH
- Telmisartan, Ramipril, or Both in Patients at High Risk of Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now